Lexicon Pharmaceuticals (LXRX) Interest & Investment Income (2010 - 2014)
Lexicon Pharmaceuticals (LXRX) reported Interest & Investment Income of $5000.0 for Q3 2014, down 87.18% year-over-year from $39000.0 in Q3 2013, and up 25.0% quarter-over-quarter from $4000.0 in Q2 2014.
Lexicon Pharmaceuticals (LXRX) Interest & Investment Income (2010 - 2014) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has 5 years of Interest & Investment Income data on file, last reported at $5000.0 in Q3 2014.
- Interest & Investment Income for Q3 2014 came in at $5000.0, down 87.18% year-over-year; the trailing twelve-month figure through Sep 2014 was $38000.0 (down 80.1% YoY), and the FY2013 annual result was $157000.0, down 26.29% from the prior year.
- Interest & Investment Income climbed to $5000.0 in Q3 2014 per LXRX's latest filing, from $4000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $200000.0 in Q2 2010 and troughed at $4000.0 in Q2 2014.
- A 5-year average of $52444.4 and a median of $51000.0 in 2010 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2012 and 2014: Interest & Investment Income soared 37.5% in 2012, then tumbled 90.91% in 2014.
- A 5-year view of Interest & Investment Income shows it stood at $51000.0 in 2010, then declined by 21.57% to $40000.0 in 2011, then soared by 37.5% to $55000.0 in 2012, then slumped by 61.82% to $21000.0 in 2013, then slumped by 76.19% to $5000.0 in 2014.
- Business Quant data shows LXRX's Interest & Investment Income at $5000.0 in Q3 2014, $4000.0 in Q2 2014, and $8000.0 in Q1 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Lexicon Pharmaceuticals | 804.48 Mn | 633.82 Mn | 20.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 5,000.00 |
| Jun 30, 2014 | 4,000.00 |
| Mar 31, 2014 | 8,000.00 |
| Dec 31, 2013 | 21,000.00 |
| Sep 30, 2013 | 39,000.00 |
| Jun 30, 2013 | 44,000.00 |
| Mar 31, 2013 | 53,000.00 |
| Dec 31, 2012 | 55,000.00 |
| Sep 30, 2012 | 44,000.00 |
| Jun 30, 2012 | 58,000.00 |
| Mar 31, 2012 | 56,000.00 |
| Dec 31, 2011 | 40,000.00 |
| Sep 30, 2011 | 60,000.00 |
| Jun 30, 2011 | 68,000.00 |
| Mar 31, 2011 | 87,000.00 |
| Dec 31, 2010 | 51,000.00 |
| Sep 30, 2010 | 51,000.00 |
| Jun 30, 2010 | 200,000.00 |